5 reports of this reaction
4.3% of all BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE reports
#3 most reported adverse reaction
DRUG ABUSE is the #3 most commonly reported adverse reaction for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE, manufactured by Accord Healthcare, Inc. There are 5 FDA adverse event reports linking BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE to DRUG ABUSE. This represents approximately 4.3% of all 116 adverse event reports for this drug.
Patients taking BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE who experience drug abuse should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG ABUSE is moderately reported among BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE users, representing a notable but not dominant share of adverse events.
In addition to drug abuse, the following adverse reactions have been reported for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE:
The following drugs have also been linked to drug abuse in FDA adverse event reports:
DRUG ABUSE has been reported as an adverse event in 5 FDA reports for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG ABUSE accounts for approximately 4.3% of all adverse event reports for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE, making it one of the most commonly reported side effect.
If you experience drug abuse while taking BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.